22
total announcements
BLUEJET.NS · 15 min delayed
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange about the publication of information regarding the 58th Annual General Meeting through Video Conferencing/Other Audio Visual Means.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the FY 2025-26'. The report is available on the Company's website and has been submitted to the Exchange.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 21, 2026. The meeting will consider and pass resolutions for the re-appointment of Mr. Akshay Bansarilal Arora as the Whole-Time Director and Executive Chairman of the Company, payment of remuneration to Mr. Akshay Bansarilal Arora and Mr. Shiven Akshay Arora, and the re-appointment of M/s. KKC & Associates LLP as the Statutory Auditors of the Company.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange about the publication of a newspaper advertisement regarding the 58th Annual General Meeting through video conferencing/audio visual means and record date for final dividend.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange about the transcript of the Earnings Call with Analysts/Investors on the Financial Results for the quarter ended June 30, 2026. The company reported revenue from operations of INR293 crores and an EBITDA of INR98 crores, reflecting healthy sequential improvement. The improvement during this quarter was primarily supported by stronger performance in the PI vertical, following the normalization of customer inventory while the contrast media and high-intensity sweetener businesses continue to provide stability and diversification to the portfolio.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has published unaudited standalone financial results for the quarter ended June 30, 2026, as per Regulation 47 of the SEBI (LODR) Regulations, 2015.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange about the link to the recording of their earnings conference call for the quarter ended June 30, 2026, which is available on their website.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange about Presentation on Financial Results for the first quarter ended June 30, 2026. The company has seen a 25% increase in revenue from operations, 38% increase in EBITDA, and 22% increase in PAT compared to the previous quarter. However, revenue from operations decreased by 17% and EBITDA decreased by 19% compared to the same quarter last year.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange that Record date for the purpose of Dividend is 14-Sep-2026. The company has also announced unaudited financial results for the first quarter ended June 30, 2026, and has re-appointed Mr. Akshay B Arora as the Whole Time Director and Executive Chairman, and Mr. Shiven Akshay Arora as the Managing Director for a further period of five years.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 03, 2026, where the Board of Directors approved the unaudited standalone financial results for the first quarter ended June 30, 2026, re-appointment of directors, and other matters.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 03, 2026, where the Board of Directors approved the unaudited standalone financial results for the first quarter ended June 30, 2026, re-appointment of directors, and other matters.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and announced the re-appointment of its Whole Time Director and Executive Chairman, Managing Director, and Statutory Auditors. The company has also set a record date for a dividend of Rs. 1.2 per equity share and scheduled its 58th Annual General Meeting for September 21, 2026.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has scheduled a conference call to discuss its unaudited standalone financial results for the quarter ended June 30, 2026.
Blue Jet Healthcare Limited
Akshay Bansarilal Arora and persons acting in concert have made a declaration under SEBI Takeover Regulations that they have not made any encumbrance on their equity holding in Blue Jet Healthcare Limited during the financial year ended 31 March 2026.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has been awarded the EcoVadis Silver Medal for its outstanding sustainability management practices, ranking among the top 15% of companies globally.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming that the company's shares are in demat form and no requests for rematerialization were received during the quarter ended June 30, 2026.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange regarding 'outcome of Investment and Finance Committee' Meeting. The company has approved the issue and allotment of 15,810,276 Equity Shares eligible qualified institutional buyers at the issue price of ₹ 506.00 per Equity Share, aggregating ₹ 8000.00 million. The paid-up equity share capital of the Company stands increased from ₹ 346,930,850 to ₹ 378,551,402.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange regarding the Investment and Finance Committee meeting held on July 9, 2026, where the committee approved the closure of the qualified institutions placement of equity shares, allocation of shares, and adoption of the Placement Document.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange regarding the outcome of its Investment and Finance Committee meeting, which approved the preliminary placement document for a qualified institutions placement of equity shares, fixed the floor price at ₹ 531.70 per share, and authorized the opening of the issue.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has submitted its audited standalone financial statements for the financial year ended March 31, 2026, to the NSE. The financial statements are subject to adoption by the shareholders at the ensuing Annual General Meeting.